prl- null vector (Promega)
Structured Review
Prl Null Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prl-+null+vector/prl+null+vector/pm38954637-300-1-4
Average 90 stars, based on 1 article reviews
Images
Related Articles
Plasmid Preparation:Article Title: YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. Article Snippet: The Hippo pathway is generally understood to inhibit tumor growth by phosphorylating the transcriptional cofactor YAP to sequester it to the cytoplasm and reduce the formation of YAPTEAD transcriptional complexes.. Aberrant activation of YAP occurs in various cancers.. However, we found a tumorsuppressive function of YAP in clear cell renal cell carcinoma (ccRCC). Expressing:Article Title: YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. Article Snippet: The Hippo pathway is generally understood to inhibit tumor growth by phosphorylating the transcriptional cofactor YAP to sequester it to the cytoplasm and reduce the formation of YAPTEAD transcriptional complexes.. Aberrant activation of YAP occurs in various cancers.. However, we found a tumorsuppressive function of YAP in clear cell renal cell carcinoma (ccRCC). Luciferase:Article Title: YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. Article Snippet: The Hippo pathway is generally understood to inhibit tumor growth by phosphorylating the transcriptional cofactor YAP to sequester it to the cytoplasm and reduce the formation of YAPTEAD transcriptional complexes.. Aberrant activation of YAP occurs in various cancers.. However, we found a tumorsuppressive function of YAP in clear cell renal cell carcinoma (ccRCC). Control:Article Title: YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. Article Snippet: The Hippo pathway is generally understood to inhibit tumor growth by phosphorylating the transcriptional cofactor YAP to sequester it to the cytoplasm and reduce the formation of YAPTEAD transcriptional complexes.. Aberrant activation of YAP occurs in various cancers.. However, we found a tumorsuppressive function of YAP in clear cell renal cell carcinoma (ccRCC). |
